Back to Map
RECRUITING
Updated: Nov 28, 2025
Gut Peptides and Bone Remodeling in Children With Neuromuscular Disorders
Phase
N/A
Early 1
1
2
3
4
Brief Summary
Both GIP and GLP-2 reduce bone resorption (measured as CTX) in healthy adult individuals. In this study, we will investigate whether GIP and GLP-2 reduce CTX in children with spinal muscular atrophy, duchenne muscular dystrophy, or cerebral palsy.
Key Information
Participation Criteria
Study Design
Locations & Contacts
Inclusion Criteria:
- Diagnosis with Cerebral palsy (CP), Duchenne muscular dystrophy (DMD) or Spinal muscular atrophy (SMA) resulting in the need of a wheelchair
Exclusion Criteria:
- Use of anti-resorptive medication
- Confounding illnesses
- Pregnancy
- Allergy towards the components given on the test days
- Hgb<6.5 mmol/L